Change of safety interval from hyperviscosity problem in COVID-19 vaccine recipient with underlying diabetic problem
Saved in:
Main Authors: | Pathum Sookaromdee, Viroj Wiwanitkit |
---|---|
Format: | article |
Language: | EN |
Published: |
Wolters Kluwer Medknow Publications
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/16549c0c94e54b9b9db27c4710432494 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Living-donor parathyroid cells allotransplantation in a kidney transplant recipient – Two-year results
by: Vladimir Khryshchanovich, et al.
Published: (2021) -
Applying a women's health lens to endocrine and metabolic disorders
by: Usha Sriram
Published: (2021) -
Prevalence of frailty in middle-aged diabetic population of Ahmedabad: A cross-sectional study
by: Priyal P Bhatt, et al.
Published: (2021) -
Diabetes, COVID-19 and mucormycosis: Unanswered questions!
by: Ashu Rastogi, et al.
Published: (2021) -
When the DHOL is beating, BHANGRA comes to the rescue!
by: Gagan Priya, et al.
Published: (2021)